Literature DB >> 24100966

Polypill improves adherence but fails to win all scientists' hearts.

Alla Katsnelson.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24100966     DOI： 10.1038/nm1013-1192

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

1.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Authors:  S Yusuf; P Pais; R Afzal; D Xavier; K Teo; J Eikelboom; A Sigamani; V Mohan; R Gupta; N Thomas
Journal:  Lancet       Date:  2009-03-30       Impact factor: 79.321

2.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

3.  Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.

Authors:  Simon Thom; Neil Poulter; Jane Field; Anushka Patel; Dorairaj Prabhakaran; Alice Stanton; Diederick E Grobbee; Michiel L Bots; K Srinath Reddy; Raghu Cidambi; Severine Bompoint; Laurent Billot; Anthony Rodgers
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272
  3 in total
  1 in total

1.  Could patents interfere with the development of a cardiovascular polypill?

Authors:  Reed F Beall; Jon-David R Schwalm; Mark D Huffman; Tara McCready; Salim Yusuf; Amir Attaran
Journal:  J Transl Med       Date:  2016-08-18       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.